Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.81 USD
Change Today +0.04 / 5.19%
Volume 928.1K
DARA On Other Exchanges
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

dara biosciences inc (DARA) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/28/14 - $2.38
52 Week Low
04/1/15 - $0.68
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for DARA BIOSCIENCES INC (DARA)

Related News

No related news articles were found.

dara biosciences inc (DARA) Related Businessweek News

No Related Businessweek News Found

dara biosciences inc (DARA) Details

DARA BioSciences, Inc., a specialty pharmaceutical company, focuses on commercialization of oncology treatment and supportive care pharmaceutical products in the United States. The company’s products comprise Soltamox, an oral solution for the chronic treatment of breast cancer or for cancer prevention in certain susceptible breast cancer subgroups; Gelclair, an oral gel for the treatment of oral mucositis; Bionect for the management of irritation of the skin, as well as first and second degree burns; Ferralet 90 for treatment of anemia; and Aquoral for treatment of cancer. Its clinical development products include KRN5500, a novel, non-narcotic/non-opioid intravenous product for the treatment of cancer patients with painful chronic chemotherapy induced peripheral neuropathy, which has completed Phase 2a development. The company was incorporated in 2002 and is headquartered in Raleigh, North Carolina.

15 Employees
Last Reported Date: 03/3/15
Founded in 2002

dara biosciences inc (DARA) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $464.4K
Executive Chairman and Chief Medical Officer
Total Annual Compensation: $487.5K
Chief Financial Officer, Chief Accounting Off...
Total Annual Compensation: $300.0K
Compensation as of Fiscal Year 2014.

dara biosciences inc (DARA) Key Developments

DARA BioSciences, Inc. Announces Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014

DARA BioSciences Inc. announced earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported net revenues of $717,800 against $53,600 a year ago. Net loss attributed to controlling interest was $1,649,500 against $2,354,100 a year ago. The company reported a loss of $0.04 per share. For the year, the company reported net revenues of $1.89 million based on gross product sales of $2.32 million, as compared to net revenues of $419,000 for the year ended December 31, 2013, a year over year increase of 350%. The increase in Revenue was primarily attributable to the expanded commercial sales organization and success in generating interest and prescriptions across DARA's portfolio. The company reported a loss attributable to controlling interest of approximately $9.00 million or $0.63 per share as compared to a loss attributable to controlling interest of approximately $9.97 million, or $1.94 per share for the full year ended December 31, 2013. The loss attributable to controlling interest for the year was $963,887 less than the same period last year.

DARA BioSciences, Inc to Report Q4, 2014 Results on Mar 03, 2015

DARA BioSciences, Inc announced that they will report Q4, 2014 results After-Market on Mar 03, 2015

DARA BioSciences, Inc, Q4 2014 Earnings Call, Mar 04, 2015

DARA BioSciences, Inc, Q4 2014 Earnings Call, Mar 04, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DARA:US $0.81 USD +0.04

DARA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
PlasmaTech Biopharmaceuticals Inc $3.78 USD +0.15
View Industry Companies

Industry Analysis


Industry Average

Valuation DARA Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DARA BIOSCIENCES INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at